Mosquito News and Research

RSS

New findings could develop effective vaccines or treatments for chikungunya fever

Researchers at Albert Einstein College of Medicine have found that the virus responsible for chikungunya fever can spread directly from cell to cell-;perhaps solving the longstanding mystery of how the virus, now emerging as a major health threat, can manage to escape antibodies circulating in the bloodstream.

18 Aug 2023

WHO updates recommendation for malaria-preventing mosquito nets based on new research

The World Health Organisation (WHO) has updated its recommendation for malaria-preventing mosquito nets based on new research from the University of Adelaide.

17 Aug 2023

Research shows how mosquito-transmitted viruses hijack host cells to promote infection

New Cleveland Clinic research shows how mosquito-transmitted viruses – like Zika, West Nile, Yellow Fever and dengue viruses – hijack host cells to promote their own replication and infection.

16 Aug 2023

Inflammation slows down the development of malaria parasites in bloodstream

Research led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Kirby Institute found that inflammation in the body can slow down the development of malaria parasites in the bloodstream – a discovery that may constitute a potential new strategy for preventing or limiting severe disease.

8 Aug 2023

Clinicians must be vigilant for malaria cases in non-endemic countries, experts warn

Following the identification of the first locally acquired malaria cases in the US in 20 years, experts warn in an Annals of Internal Medicine commentary that nations could see worrisome resurgences of the disease without increased efforts to improve global detection and treatment.

8 Aug 2023

NIH awards $18 million to develop novel chikungunya vaccine

The Access to Advanced Health Institute (AAHI) announced today that it has received an $18 million award from the National Institutes of Health (NIH) to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

3 Aug 2023

Expert warns of the increasing risks of European holidays

As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.

28 Jul 2023

Research reveals detrimental effects of maternal dengue infections on birth outcomes

Detrimental effects of all severities of maternal dengue infections on birth outcomes have been discovered in a new research study from the University of Surrey and the University of Birmingham.

11 Jul 2023

Tick season is here: How to avoid ticks

It's tick season now and researchers from the University of Agder in Norway shed light on the myths and facts about these parasites.

7 Jul 2023

Dengue outbreak overlapped COVID-19 crisis in Key Largo, Florida in 2020: Call for enhanced disease testing protocols

Detection and response to a dengue outbreak in Florida during the COVID-19 pandemic in 2020, highlighting the challenges of diagnosing febrile illnesses and the need for surveillance. This study examines the impact and management of dengue cases in the context of the ongoing pandemic.

5 Jul 2023

New CRISPR-based system could eliminate malaria-carrying mosquitoes

Malaria remains one of the world's deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five.

5 Jul 2023

Climate change's impact on health and healthcare in Northern NSW: Urgent action needed

A systematic review published in the International Journal of Environmental Research and Public Health describes the impact of climate change on health and health services in Northern New South Wales, Australia. This region is considered a “hotspot” for floods and bushfires in Australia.

4 Jul 2023

New regulatory system discovered in malaria parasite

Gene expression within the apicoplast, an organelle in the malaria parasite Plasmodium falciparum, is regulated by melatonin (the circadian signaling hormone) in host blood, and intrinsic parasite cues, via a factor called ApSigma, as identified by a recent study aided by Tokyo Tech's World Research Hub Initiative.

3 Jul 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Europe's battle against Aedes mosquitoes: growing threat of mosquito-borne diseases

Study described how cases of all types of mosquito-borne diseases are increasing in Europe.

26 Jun 2023

Disorientating the malaria parasite to prevent its replication and transmission

With almost 250 million cases a year, 621,000 of them fatal, malaria remains a major public health problem, particularly in sub-Saharan Africa.

16 Jun 2023

Phase 3 clinical trial shows favorable safety and immunogenicity profile of single-shot live-attenuated chikungunya vaccine

Researchers performed a double-blinded, phase III randomized trial.

15 Jun 2023

"Homing gene drive system" could help suppress agricultural pests

Researchers have developed a "homing gene drive system" based on CRISPR/Cas9 that could be used to suppress populations of Drosophila suzukii vinegar flies – so-called "spotted-wing Drosophila" that devastate soft-skinned fruit in North America, Europe and parts of South America – according to new research from North Carolina State University.

12 Jun 2023

VLA1553 vaccine candidate for chikungunya disease produces an immune response in a phase 3 trial

The VLA1553 vaccine candidate for chikungunya disease was generally well tolerated and produced an immune response in 99% (263/266) of participants, according to a phase 3 randomized controlled trial published in The Lancet.